Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Measles (mmu05162)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Adar
KLA  ATP  ATP+KLA
 NM_001038587 adenosine deaminase, RNA-specific (Adar), transcript variant 1, mRNA [NM_001038587] KLA 5.28 5.13 4.53 4.02 4.14 3.44 2.88
ATP 1.30 1.41 1.07 1.26 1.55 3.27 2.25
KLA/ATP 5.63 6.36 4.32 6.87 6.03 6.89 6.51
Adar
KLA  ATP  ATP+KLA
 NM_019655 adenosine deaminase, RNA-specific (Adar), transcript variant 1, mRNA [NM_019655] KLA 4.04 4.23 4.16 3.97 3.67 3.70 3.37
ATP 1.05 1.05 .80 .67 .74 3.23 3.93
KLA/ATP 4.62 4.13 3.21 3.21 2.14 5.80 8.51
Akt1
KLA  ATP  ATP+KLA
 NM_009652 thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] KLA .80 .80 .75 .75 .71 .70 .82
ATP 1.00 1.02 .76 .85 .76 .68 .84
KLA/ATP .82 .80 .64 .68 .67 .61 .72
Akt2
KLA  ATP  ATP+KLA
 NM_007434 thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] KLA 1.45 1.49 1.81 1.61 1.83 1.17 .92
ATP 1.12 1.12 1.00 1.28 1.20 .94 1.06
KLA/ATP 1.48 1.70 1.69 1.58 1.57 1.32 1.27
Akt3
KLA  ATP  ATP+KLA
 NM_011785 thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] KLA 3.42 3.45 5.31 5.16 4.65 3.80 2.12
ATP 1.12 1.22 1.10 1.37 1.02 1.11 1.56
KLA/ATP 3.72 4.17 4.62 4.64 2.74 2.05 3.82
BB229853
KLA  ATP  ATP+KLA
 BB229853 gb|BB229853 RIKEN full-length enriched, 3 days neonate thymus Mus musculus cDNA clone A630023O21 3. [BB229853] KLA 6.32 5.94 6.13 6.41 7.39 12.33 6.08
ATP .39 .24 .33 .38 1.18 5.75 2.85
KLA/ATP 2.27 2.02 3.25 4.04 7.11 10.22 13.93
Bbc3
KLA  ATP  ATP+KLA
 NM_133234 Bcl-2 binding component 3 (Bbc3), mRNA [NM_133234] KLA 1.53 1.37 1.05 1.26 .85 .64 .53
ATP .80 .68 .56 1.03 .64 .80 .35
KLA/ATP 1.40 1.09 .81 1.05 1.72 1.13 .54
Cblb
KLA  ATP  ATP+KLA
 AK045005 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130018P07 product:hypothetical protein, full insert sequence. [AK045005] KLA 1.16 1.11 1.15 1.10 1.16 .98 .93
ATP 1.16 1.23 .98 1.28 1.34 .73 1.55
KLA/ATP 1.26 1.60 1.64 1.23 1.01 .91 1.05
Cblb
KLA  ATP  ATP+KLA
 AK084162 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230004I05 product:unclassifiable, full insert sequence. [AK084162] KLA .97 .98 1.02 1.01 .84 1.02 1.03
ATP 1.03 1.02 .98 1.09 1.05 .96 .96
KLA/ATP 1.07 .95 .91 .98 .98 1.01 1.00
Ccnd1
KLA  ATP  ATP+KLA
 S78355 gb|Cyl-1=cyclin D1 [mice, BALB/c, brain, mRNA, 3737 nt]. [S78355] KLA .24 .23 .23 .24 .29 .47 .17
ATP 1.02 1.02 .88 .80 .52 .10 .21
KLA/ATP .27 .23 .22 .24 .27 .25 .14
Ccnd2
KLA  ATP  ATP+KLA
 NM_009829 cyclin D2 (Ccnd2), mRNA [NM_009829] KLA 12.92 13.66 11.94 12.37 11.11 5.44 1.53
ATP .98 .75 .50 .57 1.24 2.83 .40
KLA/ATP 11.19 11.62 10.34 7.96 7.92 7.10 2.57
Ccnd3
KLA  ATP  ATP+KLA
 NM_007632 cyclin D3 (Ccnd3), transcript variant 1, mRNA [NM_007632] KLA .60 .65 .86 1.02 1.91 2.26 1.45
ATP 1.05 1.14 .89 1.20 .74 .76 .99
KLA/ATP .70 .67 .54 .83 .61 1.19 1.45
Ccne1
KLA  ATP  ATP+KLA
 NM_007633 cyclin E1 (Ccne1), mRNA [NM_007633] KLA 1.13 1.14 1.13 .78 .51 .69 .55
ATP .92 .94 1.09 .93 .75 .71 .47
KLA/ATP 1.13 1.17 1.45 1.24 1.33 1.50 .85
Ccne2
KLA  ATP  ATP+KLA
 NM_001037134 cyclin E2 (Ccne2), transcript variant 1, mRNA [NM_001037134] KLA .34 .35 .42 .36 .35 .36 .26
ATP 1.02 1.11 1.01 .82 .58 .38 .23
KLA/ATP .36 .34 .44 .43 .41 .40 .25
Cd209a
KLA  ATP  ATP+KLA
 NM_133238 CD209a antigen (Cd209a), mRNA [NM_133238] KLA .97 .98 1.09 .99 1.01 .96 1.02
ATP .97 1.00 1.12 .94 .96 .99 .89
KLA/ATP .99 1.03 1.08 1.01 1.01 1.08 1.01
Cd209b
KLA  ATP  ATP+KLA
 NM_001037800 CD209b antigen (Cd209b), transcript variant 2, mRNA [NM_001037800] KLA 1.00 1.01 1.01 1.03 1.00 .97 1.04
ATP 1.00 1.03 1.02 .95 1.00 .91 .94
KLA/ATP .94 1.00 .96 .97 .98 1.02 1.05
Cd209c
KLA  ATP  ATP+KLA
 NM_130903 CD209c antigen (Cd209c), mRNA [NM_130903] KLA 1.02 1.03 1.02 1.01 1.09 1.02 1.00
ATP .97 1.05 1.02 1.02 1.02 1.03 1.04
KLA/ATP .98 .95 1.09 1.02 .99 1.04 .99
Cd209d
KLA  ATP  ATP+KLA
 NM_130904 CD209d antigen (Cd209d), mRNA [NM_130904] KLA .96 1.00 1.03 1.04 .95 .97 1.01
ATP .99 .97 .97 1.02 .97 .95 1.05
KLA/ATP 1.04 1.08 .99 1.02 .95 .99 1.05
Cd209e
KLA  ATP  ATP+KLA
 NM_130905 CD209e antigen (Cd209e), mRNA [NM_130905] KLA 1.02 1.05 1.01 1.01 1.00 1.03 .96
ATP .96 .94 1.03 1.10 1.01 1.03 1.09
KLA/ATP .99 .99 .95 1.03 1.05 1.01 1.00
Cd28
KLA  ATP  ATP+KLA
 NM_007642 CD28 antigen (Cd28), mRNA [NM_007642] KLA .52 .51 .45 .50 .36 .33 .18
ATP 1.11 1.26 1.08 1.25 1.99 1.42 2.08
KLA/ATP .51 .51 .58 .60 .56 .53 .38
Cd3d
KLA  ATP  ATP+KLA
 NM_013487 CD3 antigen, delta polypeptide (Cd3d), mRNA [NM_013487] KLA 1.01 1.05 1.00 .95 .98 1.03 1.02
ATP 1.02 .94 1.08 .99 .99 .94 1.05
KLA/ATP .93 .91 .99 .98 .96 .96 1.04
Cd3e
KLA  ATP  ATP+KLA
 NM_007648 CD3 antigen, epsilon polypeptide (Cd3e), mRNA [NM_007648] KLA 1.21 1.25 1.29 1.22 1.29 1.32 1.13
ATP .98 1.00 1.10 1.11 1.10 1.19 1.11
KLA/ATP 1.24 1.30 1.32 1.30 1.22 1.19 1.10
Cd3g
KLA  ATP  ATP+KLA
 NM_009850 CD3 antigen, gamma polypeptide (Cd3g), mRNA [NM_009850] KLA 1.05 1.01 .96 1.01 1.02 .99 .99
ATP .94 .97 .99 .99 .95 1.02 1.07
KLA/ATP .95 .92 1.08 1.03 1.01 1.01 .99
Cd46
KLA  ATP  ATP+KLA
 AK047275 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930044L09 product:unclassifiable, full insert sequence [AK047275] KLA 1.14 1.04 1.06 1.07 1.06 .98 .99
ATP .98 .88 1.04 .94 .94 .96 1.04
KLA/ATP 1.05 .98 1.06 1.04 1.03 1.07 1.00
Cd46
KLA  ATP  ATP+KLA
 NM_010778 CD46 antigen, complement regulatory protein (Cd46), mRNA [NM_010778] KLA 1.05 .97 .99 .95 1.01 1.08 .99
ATP .97 .94 .95 .93 .94 1.04 1.06
KLA/ATP 1.02 .95 1.01 .98 .95 .94 1.04
Cdk2
KLA  ATP  ATP+KLA
 NM_016756 cyclin-dependent kinase 2 (Cdk2), transcript variant 2, mRNA [NM_016756] KLA .68 .67 .62 .63 .60 .74 .73
ATP 1.02 1.14 .91 .92 .68 .71 .65
KLA/ATP .67 .64 .64 .64 .61 .74 .62
Cdk4
KLA  ATP  ATP+KLA
 NM_009870 cyclin-dependent kinase 4 (Cdk4), mRNA [NM_009870] KLA .66 .72 .65 .55 .46 .50 .71
ATP 1.03 1.02 .53 .65 .66 .63 .75
KLA/ATP .78 .61 .31 .42 .44 .62 .43
Cdk6
KLA  ATP  ATP+KLA
 AK030810 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830411I20 product:unclassifiable, full insert sequence [AK030810] KLA 1.05 .96 .67 .51 .48 .49 .45
ATP 1.02 .91 .78 .49 .50 .47 .44
KLA/ATP 1.01 .89 .65 .40 .36 .26 .49
Cdk6
KLA  ATP  ATP+KLA
 NM_009873 cyclin-dependent kinase 6 (Cdk6), mRNA [NM_009873] KLA 2.63 2.36 2.14 1.80 1.55 1.32 1.03
ATP 1.11 1.21 1.06 1.23 .94 1.30 2.08
KLA/ATP 2.58 2.69 2.24 2.25 1.38 .85 3.00
Cdkn1b
KLA  ATP  ATP+KLA
 NM_009875 cyclin-dependent kinase inhibitor 1B (Cdkn1b), mRNA [NM_009875] KLA .81 .84 .84 .91 .93 .88 .97
ATP .99 1.09 .97 1.06 1.48 .94 .91
KLA/ATP .83 .91 1.04 1.36 1.48 1.06 1.09
Chuk
KLA  ATP  ATP+KLA
 NM_007700 conserved helix-loop-helix ubiquitous kinase (Chuk), mRNA [NM_007700] KLA 1.32 1.42 1.41 1.17 1.32 1.22 1.40
ATP 1.22 1.30 1.18 .97 1.02 1.00 1.37
KLA/ATP 1.56 1.61 1.21 1.09 .83 .84 1.17
Csnk2a1
KLA  ATP  ATP+KLA
 NM_007788 casein kinase 2, alpha 1 polypeptide (Csnk2a1), mRNA [NM_007788] KLA 1.36 1.39 1.19 1.34 1.32 1.74 1.86
ATP .92 .88 1.13 .86 1.12 2.50 1.99
KLA/ATP 1.19 1.24 1.35 1.03 1.16 2.09 2.88
Csnk2a2
KLA  ATP  ATP+KLA
 NM_009974 casein kinase 2, alpha prime polypeptide (Csnk2a2), mRNA [NM_009974] KLA 1.46 1.53 1.70 1.47 1.32 1.32 1.17
ATP 1.00 1.11 1.17 1.33 1.71 2.03 1.06
KLA/ATP 1.58 1.67 1.69 2.00 2.20 2.44 1.68
Csnk2b
KLA  ATP  ATP+KLA
 NM_009975 casein kinase 2, beta polypeptide (Csnk2b), mRNA [NM_009975] KLA 1.19 1.10 1.12 1.13 1.20 1.28 1.25
ATP 1.12 1.03 1.04 1.07 1.20 1.27 1.09
KLA/ATP 1.15 1.20 1.25 1.13 1.44 1.34 1.35
D430028G
21Rik
KLA  ATP  ATP+KLA
 NM_144888 RIKEN cDNA D430028G21 gene (D430028G21Rik), mRNA [NM_144888] KLA .56 .54 .61 .60 .74 1.03 1.06
ATP 1.07 .99 .69 .66 .48 .96 1.38
KLA/ATP .61 .60 .38 .41 .42 1.00 1.40
Ddx58
KLA  ATP  ATP+KLA
 NM_172689 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (Ddx58), mRNA [NM_172689] KLA 8.80 9.12 9.70 9.96 9.92 7.85 5.67
ATP 1.06 .89 .97 .89 .80 3.03 3.67
KLA/ATP 9.18 9.23 10.31 9.25 7.29 6.93 8.99
Dok1
KLA  ATP  ATP+KLA
 NM_010070 docking protein 1 (Dok1), mRNA [NM_010070] KLA .83 .83 .89 .85 1.09 1.55 1.53
ATP 1.08 1.06 .83 .74 .54 .81 1.73
KLA/ATP .94 .98 .83 .71 .61 .90 2.30
EG629860
KLA  ATP  ATP+KLA
 M17953 gb|Mouse Ig rearranged H-chain V-region mRNA VJ1 [M17953] KLA .96 1.05 1.03 1.08 1.08 1.02 .98
ATP .97 .99 1.05 1.10 .95 .94 .91
KLA/ATP .96 .94 .97 1.04 .97 1.01 .89
Eif2ak1
KLA  ATP  ATP+KLA
 AK032508 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430574E03 product:EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 (EC 2.7.1.-) (HEME-REGULATED EUKARYOTIC INITIATION FACTOR EIF-2-ALPHA KINASE) (HEME-R KLA .65 .66 .65 .67 .67 .85 1.06
ATP 1.07 1.13 1.10 1.03 .70 .63 .72
KLA/ATP .68 .73 .70 .67 .65 .66 .47
Eif2ak1
KLA  ATP  ATP+KLA
 NM_013557 eukaryotic translation initiation factor 2 alpha kinase 1 (Eif2ak1), mRNA [NM_013557] KLA 1.16 1.19 1.32 1.21 1.58 1.51 1.59
ATP 1.19 1.27 .93 1.28 1.02 1.53 1.60
KLA/ATP 1.36 1.50 1.16 1.38 1.12 1.79 2.42
Eif2ak2
KLA  ATP  ATP+KLA
 NM_011163 eukaryotic translation initiation factor 2-alpha kinase 2 (Eif2ak2), mRNA [NM_011163] KLA 6.20 6.38 6.31 6.36 4.86 4.86 2.93
ATP 1.03 .78 .68 .37 .49 3.38 1.97
KLA/ATP 6.50 5.52 5.25 2.87 3.90 4.33 3.35
Eif2ak3
KLA  ATP  ATP+KLA
 AK041698 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630030N06 product:unclassifiable, full insert sequence. [AK041698] KLA .79 .77 .83 .80 .93 .87 .85
ATP .82 .82 .82 .92 .88 .85 .91
KLA/ATP .77 .76 .78 .80 .84 .86 .81
Eif2ak3
KLA  ATP  ATP+KLA
 NM_010121 eukaryotic translation initiation factor 2 alpha kinase 3 (Eif2ak3), mRNA [NM_010121] KLA .28 .28 .27 .29 .38 .36 .47
ATP 1.17 1.04 .62 .48 .54 .48 .67
KLA/ATP .29 .30 .26 .26 .34 .37 .32
Eif2ak4
KLA  ATP  ATP+KLA
 AF193344 GCN2gamma mRNA, complete cds [AF193344] KLA .78 .78 .66 .72 .79 .83 1.05
ATP .97 1.06 .97 .97 .98 .86 .94
KLA/ATP .81 .73 .62 .84 .81 .88 .90
Eif2ak4
KLA  ATP  ATP+KLA
 NM_013719 eukaryotic translation initiation factor 2 alpha kinase 4 (Eif2ak4), mRNA [NM_013719] KLA .60 .55 .49 .54 .59 .67 .91
ATP 1.11 1.18 1.00 .94 1.33 .90 .98
KLA/ATP .59 .54 .56 .58 .90 .86 .86
Eif2s1
KLA  ATP  ATP+KLA
 NM_026114 eukaryotic translation initiation factor 2, subunit 1 alpha (Eif2s1), mRNA [NM_026114] KLA 1.50 1.49 1.52 1.49 1.24 1.12 1.25
ATP 1.00 .98 1.16 1.05 1.03 1.10 .99
KLA/ATP 1.50 1.54 1.73 1.39 1.24 .87 .66
Eif3h
KLA  ATP  ATP+KLA
 NM_080635 eukaryotic translation initiation factor 3, subunit H (Eif3h), mRNA [NM_080635] KLA .99 .90 .96 .94 .93 .84 .78
ATP 1.07 1.08 1.01 .94 1.04 .84 .56
KLA/ATP .93 .95 1.23 .94 .88 .71 .52
Fas
KLA  ATP  ATP+KLA
 AK086933 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030012O08 product:tumor necrosis factor receptor superfamily, member 6, full insert sequence. [AK086933] KLA 6.31 6.56 6.33 6.70 4.93 3.74 2.48
ATP .95 1.04 1.33 1.55 1.85 6.00 2.77
KLA/ATP 5.67 7.16 7.71 7.73 6.02 5.79 7.85
Fas
KLA  ATP  ATP+KLA
 NM_007987 Fas (TNF receptor superfamily member 6) (Fas), mRNA [NM_007987] KLA 17.08 17.45 19.08 17.38 13.33 6.78 4.46
ATP .98 .96 1.64 3.05 5.58 12.91 1.89
KLA/ATP 16.57 17.25 26.06 23.57 22.03 16.74 13.29
Fasl
KLA  ATP  ATP+KLA
 NM_010177 Fas ligand (TNF superfamily, member 6) (Fasl), mRNA [NM_010177] KLA 1.03 1.01 1.03 1.02 1.01 1.01 1.00
ATP 1.00 .99 1.04 1.21 1.18 1.20 1.01
KLA/ATP 1.00 1.02 1.07 1.16 1.18 1.23 1.00
Fcgr2b
KLA  ATP  ATP+KLA
 NM_001077189 Fc receptor, IgG, low affinity IIb (Fcgr2b), transcript variant 1, mRNA [NM_001077189] KLA 16.93 17.57 21.75 27.43 34.13 31.88 5.70
ATP 1.11 1.09 1.17 1.46 2.81 11.26 1.92
KLA/ATP 16.51 17.91 23.67 29.22 22.67 25.33 9.54
Fcgr2b
KLA  ATP  ATP+KLA
 NM_010187 Fc receptor, IgG, low affinity IIb (Fcgr2b), transcript variant 2, mRNA [NM_010187] KLA 11.41 11.67 14.06 15.47 17.28 18.63 4.69
ATP 1.05 1.06 1.18 1.57 2.27 8.97 2.10
KLA/ATP 10.98 12.01 15.03 18.38 15.15 16.00 8.33
Fyn
KLA  ATP  ATP+KLA
 U70324 Fyn(T) (L-fyn(T)) mRNA, complete cds. [U70324] KLA 1.23 1.27 1.31 1.27 1.31 .87 .48
ATP .88 .71 .66 .75 .90 1.28 .51
KLA/ATP 1.12 1.01 .94 .84 1.25 1.51 .53
Gnb2l1
KLA  ATP  ATP+KLA
 NM_008143 guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 (Gnb2l1), mRNA [NM_008143] KLA .91 .90 .90 .93 .75 .67 .60
ATP .97 .91 .94 .92 .94 .91 .43
KLA/ATP .90 .86 .84 .79 .80 .73 .33
Gsk3b
KLA  ATP  ATP+KLA
 NM_019827 glycogen synthase kinase 3 beta (Gsk3b), mRNA [NM_019827] KLA 1.06 1.03 1.11 1.01 1.26 1.28 1.26
ATP 1.18 1.27 1.15 2.07 2.37 2.32 1.67
KLA/ATP 1.15 1.21 .98 1.50 1.67 2.50 2.99
Hspa1a
KLA  ATP  ATP+KLA
 NM_010479 heat shock protein 1A (Hspa1a), mRNA [NM_010479] KLA 7.88 6.99 4.47 5.18 7.81 11.47 4.14
ATP 1.88 5.62 43.42 58.76 55.53 28.89 9.13
KLA/ATP 7.40 7.62 28.23 54.12 70.14 43.09 22.49
Hspa1b
KLA  ATP  ATP+KLA
 NM_010478 heat shock protein 1B (Hspa1b), mRNA [NM_010478] KLA 5.01 4.73 3.77 3.62 4.81 6.53 3.12
ATP 1.34 3.07 14.11 17.14 17.51 11.21 4.82
KLA/ATP 5.04 5.15 11.63 19.94 20.84 15.79 9.30
Hspa1l
KLA  ATP  ATP+KLA
 NM_013558 heat shock protein 1-like (Hspa1l), mRNA [NM_013558] KLA .98 1.04 1.10 1.21 1.51 1.97 1.86
ATP 1.03 1.08 1.07 1.14 .93 1.21 1.89
KLA/ATP 1.06 1.01 .99 1.09 .97 1.39 2.87
Hspa2
KLA  ATP  ATP+KLA
 NM_008301 heat shock protein 2 (Hspa2), transcript variant 1, mRNA [NM_008301] KLA .98 .97 1.12 1.23 1.20 1.72 1.38
ATP 1.01 1.10 1.45 3.12 2.45 1.98 .98
KLA/ATP .99 1.12 1.52 2.60 2.89 2.62 1.18
Hspa8
KLA  ATP  ATP+KLA
 NM_031165 heat shock protein 8 (Hspa8), mRNA [NM_031165] KLA 1.00 .98 1.27 1.18 1.45 1.60 1.31
ATP 1.22 1.18 1.07 1.44 1.07 .53 .57
KLA/ATP 1.18 1.22 1.14 1.08 .93 .82 .77
Ifih1
KLA  ATP  ATP+KLA
 NM_027835 interferon induced with helicase C domain 1 (Ifih1), mRNA [NM_027835] KLA 37.11 33.14 35.90 33.98 21.58 12.10 6.89
ATP 1.03 .97 .74 .73 1.20 4.28 2.92
KLA/ATP 33.28 36.92 27.96 24.80 12.35 8.39 10.11
Ifna12
KLA  ATP  ATP+KLA
 NM_177361 interferon alpha 12 (Ifna12), mRNA [NM_177361] KLA 1.25 1.26 1.34 1.16 1.06 1.10 1.09
ATP 1.01 .97 1.07 1.09 1.17 1.20 1.07
KLA/ATP 1.12 1.29 1.72 1.54 1.59 1.56 1.05
Ifna13
KLA  ATP  ATP+KLA
 NM_177347 interferon alpha 13 (Ifna13), mRNA [NM_177347] KLA 1.32 1.27 1.26 1.34 1.15 1.24 1.20
ATP .95 1.08 1.29 1.79 1.41 1.22 1.08
KLA/ATP 1.36 1.35 2.04 2.81 2.07 1.44 1.19
Ifna2
KLA  ATP  ATP+KLA
 K01411 gb|Mouse alpha-interferon (MuIFN-alpha), 3 cds & untranslated mRNA [K01411] KLA 1.02 1.03 1.10 .96 .93 .99 1.01
ATP 1.02 .98 1.00 .98 1.02 .97 .95
KLA/ATP 1.02 1.04 1.18 1.08 1.13 1.04 1.01
Ifna2
KLA  ATP  ATP+KLA
 NM_010503 interferon alpha 2 (Ifna2), mRNA [NM_010503] KLA 1.08 1.06 1.07 1.06 .98 1.02 1.05
ATP .94 1.06 1.11 1.30 1.24 1.25 1.21
KLA/ATP 1.03 1.20 1.19 1.35 1.52 1.60 1.18
Ifna4
KLA  ATP  ATP+KLA
 NM_010504 interferon alpha 4 (Ifna4), mRNA [NM_010504] KLA .99 1.04 1.05 .97 1.00 .96 .99
ATP 1.01 .96 .98 1.01 1.00 1.00 .97
KLA/ATP 1.10 1.09 1.05 1.04 1.01 .97 1.01
Ifna5
KLA  ATP  ATP+KLA
 NM_010505 interferon alpha 5 (Ifna5), mRNA [NM_010505] KLA 1.15 1.23 1.51 1.26 1.03 1.06 1.05
ATP .99 .94 1.11 1.00 1.09 1.07 1.03
KLA/ATP 1.12 1.29 1.46 1.47 1.24 1.32 1.03
Ifna9
KLA  ATP  ATP+KLA
 NM_010507 interferon alpha 9 (Ifna9), mRNA [NM_010507] KLA 1.05 1.09 1.20 1.06 1.08 1.06 1.02
ATP .99 1.08 1.18 1.21 1.09 .99 .97
KLA/ATP 1.09 1.23 1.19 1.24 1.18 1.16 1.04
Ifnab
KLA  ATP  ATP+KLA
 BC116864 interferon alpha B, mRNA (cDNA clone MGC:151241 IMAGE:40126183), complete cds [BC116864] KLA 1.20 1.33 1.29 1.30 1.20 1.20 1.08
ATP .99 .99 1.00 1.25 1.13 1.19 1.04
KLA/ATP 1.30 1.39 1.44 1.48 1.49 1.54 1.22
Ifnar1
KLA  ATP  ATP+KLA
 NM_010508 interferon (alpha and beta) receptor 1 (Ifnar1), mRNA [NM_010508] KLA 1.35 1.29 1.19 1.39 1.60 1.47 1.49
ATP 1.18 1.25 .94 1.06 1.07 1.48 1.52
KLA/ATP 1.56 1.57 .98 1.43 1.08 1.79 3.54
Ifnar2
KLA  ATP  ATP+KLA
 NM_010509 interferon (alpha and beta) receptor 2 (Ifnar2), transcript variant 1, mRNA [NM_010509] KLA 1.45 1.43 1.67 1.87 2.31 1.84 1.36
ATP .99 .92 .87 1.03 1.38 1.79 1.43
KLA/ATP 1.48 1.48 1.24 1.54 1.77 2.10 2.81
Ifnb1
KLA  ATP  ATP+KLA
 NM_010510 interferon beta 1, fibroblast (Ifnb1), mRNA [NM_010510] KLA 49.82 46.57 34.05 16.05 5.94 7.31 8.49
ATP .99 1.02 1.89 4.78 6.31 4.44 1.79
KLA/ATP 49.22 61.83 134.08 144.05 110.96 31.78 11.24
Ifng
KLA  ATP  ATP+KLA
 NM_008337 interferon gamma (Ifng), mRNA [NM_008337] KLA 1.05 1.02 1.01 1.01 1.01 1.04 1.00
ATP 1.00 1.01 1.01 .98 .97 1.04 1.03
KLA/ATP 1.01 1.01 1.06 1.10 1.24 1.10 1.04
Ifngr1
KLA  ATP  ATP+KLA
 NM_010511 interferon gamma receptor 1 (Ifngr1), mRNA [NM_010511] KLA .81 .60 .37 .35 .34 .39 .54
ATP 1.05 .96 1.15 .97 .80 .67 .45
KLA/ATP .57 .57 .63 .36 .28 .33 .36
Ifngr2
KLA  ATP  ATP+KLA
 NM_008338 interferon gamma receptor 2 (Ifngr2), mRNA [NM_008338] KLA 1.45 1.49 1.74 2.22 3.22 2.42 1.96
ATP 1.11 1.03 .81 .78 1.12 1.28 1.34
KLA/ATP 1.48 1.41 1.17 1.23 1.48 1.89 2.13
Igh-VJ55
8
KLA  ATP  ATP+KLA
 AY547436 immunoglobulin heavy chain VDJ region mRNA, partial cds [AY547436] KLA 1.06 1.05 1.01 .93 1.03 .96 .93
ATP .99 1.00 1.06 .95 .96 1.06 1.05
KLA/ATP .98 .94 1.07 .95 .97 .99 1.02
Igh-VJ55
8
KLA  ATP  ATP+KLA
 CA578712 gb|K0727F04-5N NIA Mouse Hematopoietic Stem Cell (Lin- [CA578712] KLA .99 .94 1.01 1.10 .93 .97 .92
ATP .93 1.04 1.01 .98 1.05 .96 .95
KLA/ATP .99 .95 .95 .98 1.02 .98 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103412 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHA] [ENSMUST00000103412] KLA 1.01 .97 1.20 1.01 .98 1.44 1.24
ATP .99 .98 1.07 1.03 1.00 1.01 1.21
KLA/ATP .99 1.02 .96 1.03 .97 1.13 1.30
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103413 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHE] [ENSMUST00000103413] KLA 1.00 .99 1.06 1.06 .99 1.03 1.02
ATP 1.08 1.06 1.06 1.06 1.02 1.06 .95
KLA/ATP 1.00 1.04 1.09 1.02 1.06 1.02 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 U39781 J558+ IgM heavy chain mRNA, hybridoma clone ME2B7, partial cds. [U39781] KLA .93 .89 .98 .97 1.03 1.00 .94
ATP 1.04 1.02 1.08 .94 .93 .90 .79
KLA/ATP .88 .89 .97 .93 .88 .92 .82
Ikbke
KLA  ATP  ATP+KLA
 NM_019777 inhibitor of kappaB kinase epsilon (Ikbke), mRNA [NM_019777] KLA 6.03 5.91 6.38 6.89 7.05 6.70 4.74
ATP 1.02 1.11 .82 1.16 1.18 2.08 1.90
KLA/ATP 6.04 6.71 5.69 5.30 2.49 2.33 5.43
Il12a
KLA  ATP  ATP+KLA
 NM_008351 interleukin 12a (Il12a), mRNA [NM_008351] KLA 2.37 2.47 2.17 1.49 1.46 1.12 1.20
ATP 1.01 .97 1.12 1.07 1.02 1.07 1.06
KLA/ATP 2.01 2.76 2.54 1.70 1.08 1.10 1.27
Il12b
KLA  ATP  ATP+KLA
 NM_008352 interleukin 12b (Il12b), mRNA [NM_008352] KLA 194.79 211.32 198.97 173.01 142.24 40.28 3.10
ATP 1.05 1.10 1.59 1.99 2.71 2.72 1.52
KLA/ATP 191.27 223.23 280.10 224.29 183.03 68.43 10.69
Il13
KLA  ATP  ATP+KLA
 NM_008355 interleukin 13 (Il13), mRNA [NM_008355] KLA 1.08 1.05 .98 1.10 1.01 1.03 1.02
ATP 1.00 .98 1.08 .98 .99 1.05 .97
KLA/ATP .96 .96 1.09 1.02 1.04 1.01 .97
Il1a
KLA  ATP  ATP+KLA
 NM_010554 interleukin 1 alpha (Il1a), mRNA [NM_010554] KLA 32.45 35.22 31.30 20.95 28.57 18.36 19.02
ATP 1.04 1.02 2.21 5.46 11.06 32.07 3.40
KLA/ATP 32.02 41.20 35.12 46.91 28.76 42.72 57.80
Il1b
KLA  ATP  ATP+KLA
 NM_008361 interleukin 1 beta (Il1b), mRNA [NM_008361] KLA 149.78 133.59 100.91 116.58 86.48 89.37 64.72
ATP 3.49 13.96 61.44 70.91 82.12 162.79 28.18
KLA/ATP 130.32 139.00 219.12 148.17 165.44 172.57 146.98
Il2
KLA  ATP  ATP+KLA
 NM_008366 interleukin 2 (Il2), mRNA [NM_008366] KLA .96 .97 .96 1.00 .97 .97 .99
ATP 1.04 1.02 1.00 1.03 .97 .98 .97
KLA/ATP 1.01 .98 .97 1.00 .97 .97 .96
Il2ra
KLA  ATP  ATP+KLA
 AF054581 interleukin 2 receptor mRNA, 3UTR, partial sequence. [AF054581] KLA 1.76 2.05 2.73 2.46 3.58 2.68 1.13
ATP .99 .99 1.00 1.09 1.13 1.14 1.03
KLA/ATP 1.93 2.11 1.32 2.27 1.87 2.13 1.37
Il2ra
KLA  ATP  ATP+KLA
 NM_008367 interleukin 2 receptor, alpha chain (Il2ra), mRNA [NM_008367] KLA 1.33 1.29 1.46 1.43 1.82 1.57 1.15
ATP 1.02 1.03 1.01 1.02 1.01 1.12 1.05
KLA/ATP 1.30 1.46 1.36 1.41 1.22 1.47 1.66
Il2rb
KLA  ATP  ATP+KLA
 NM_008368 interleukin 2 receptor, beta chain (Il2rb), mRNA [NM_008368] KLA .92 1.00 1.00 1.00 .91 .98 1.09
ATP 1.02 .98 1.00 .95 1.02 1.04 1.04
KLA/ATP 1.03 .98 1.01 .99 .94 1.13 1.00
Il2rg
KLA  ATP  ATP+KLA
 NM_013563 interleukin 2 receptor, gamma chain (Il2rg), mRNA [NM_013563] KLA 2.97 2.92 3.73 3.39 4.04 3.45 4.83
ATP 1.25 1.41 1.04 1.82 1.48 1.12 2.89
KLA/ATP 3.65 4.34 2.42 4.70 2.62 2.54 5.15
Il4
KLA  ATP  ATP+KLA
 NM_021283 interleukin 4 (Il4), mRNA [NM_021283] KLA .94 .95 .91 .94 .91 .94 1.07
ATP 1.02 1.06 1.05 1.22 1.12 1.10 1.26
KLA/ATP .92 .96 .93 1.08 .98 1.03 1.18
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Irak1
KLA  ATP  ATP+KLA
 NM_008363 interleukin-1 receptor-associated kinase 1 (Irak1), mRNA [NM_008363] KLA .67 .67 .64 .56 .58 .58 .84
ATP 1.02 1.10 .94 1.14 .81 .54 .87
KLA/ATP .72 .72 .57 .67 .51 .43 .62
Irak4
KLA  ATP  ATP+KLA
 NM_029926 interleukin-1 receptor-associated kinase 4 (Irak4), mRNA [NM_029926] KLA .82 .86 .78 .82 .95 1.21 1.22
ATP 1.02 1.18 .95 1.10 .79 .85 .82
KLA/ATP .86 .89 .77 .90 .78 .96 .88
Irf3
KLA  ATP  ATP+KLA
 ENSMUST00000107835 ens|Interferon regulatory factor 3 (IRF-3). [Source:Uniprot/SWISSPROT;Acc:P70671] [ENSMUST00000107835] KLA .55 .56 .60 .72 .88 .88 .98
ATP .77 .58 .50 .46 .80 .97 1.03
KLA/ATP .51 .46 .49 .53 .92 .85 .79
Irf3
KLA  ATP  ATP+KLA
 NM_016849 interferon regulatory factor 3 (Irf3), mRNA [NM_016849] KLA .79 .75 .71 .83 .88 1.07 .99
ATP .92 .84 .88 .61 .54 1.27 1.22
KLA/ATP .78 .78 .75 .58 .70 1.13 1.38
Irf7
KLA  ATP  ATP+KLA
 NM_016850 interferon regulatory factor 7 (Irf7), mRNA [NM_016850] KLA 4.90 4.72 5.85 5.82 7.67 10.64 15.44
ATP 1.14 1.10 .86 1.18 .96 2.46 12.17
KLA/ATP 5.41 5.22 4.15 6.29 5.31 9.74 29.08
Irf9
KLA  ATP  ATP+KLA
 NM_008394 interferon regulatory factor 9 (Irf9), mRNA [NM_008394] KLA 1.96 1.99 2.13 1.83 1.81 1.85 1.71
ATP 1.08 1.06 .96 1.19 1.21 2.33 2.42
KLA/ATP 2.31 2.30 1.92 2.85 2.29 3.20 4.37
Jak1
KLA  ATP  ATP+KLA
 AK029232 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831433J01 product:Janus kinase 1, full insert sequence. [AK029232] KLA 1.25 1.13 1.19 1.31 1.24 1.17 1.14
ATP 1.01 1.11 .96 1.38 1.06 1.26 1.05
KLA/ATP 1.19 1.29 1.27 1.59 1.18 1.38 1.24
Jak1
KLA  ATP  ATP+KLA
 NM_146145 Janus kinase 1 (Jak1), mRNA [NM_146145] KLA 1.71 1.75 1.79 1.81 1.72 1.37 1.21
ATP 1.03 1.01 .75 1.04 1.32 1.90 1.14
KLA/ATP 1.84 1.73 1.49 2.07 2.01 1.83 1.68
Jak2
KLA  ATP  ATP+KLA
 NM_008413 Janus kinase 2 (Jak2), transcript variant 1, mRNA [NM_008413] KLA 14.86 15.05 15.42 14.15 11.46 8.81 5.47
ATP .99 1.06 1.09 1.43 2.83 4.71 1.62
KLA/ATP 13.77 14.74 14.94 12.97 7.53 9.34 9.17
Jak3
KLA  ATP  ATP+KLA
 NM_010589 Janus kinase 3 (Jak3), mRNA [NM_010589] KLA 1.46 1.56 1.79 1.62 2.05 1.72 1.65
ATP 1.11 1.19 .84 1.25 .82 .61 .71
KLA/ATP 1.76 1.82 1.10 1.74 .93 .83 1.01
LOC10004
6483
KLA  ATP  ATP+KLA
 XM_001476285 ref|PREDICTED: Mus musculus similar to casein kinase II, alpha prime subunit (LOC100046483), mRNA [XM_001476285] KLA .97 .94 .94 .88 .84 .76 .88
ATP 1.06 1.04 .89 .82 .87 .70 .56
KLA/ATP 1.03 1.00 .88 .75 .73 .66 .43
Map3k7
KLA  ATP  ATP+KLA
 NM_172688 mitogen-activated protein kinase kinase kinase 7 (Map3k7), mRNA [NM_172688] KLA 1.48 1.49 1.51 1.24 1.21 1.19 1.61
ATP 1.10 1.16 1.03 1.03 1.12 1.61 1.61
KLA/ATP 1.43 1.56 1.05 1.15 .85 1.48 1.76
Map3k7ip
2
KLA  ATP  ATP+KLA
 AK086230 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930015C19 product:inferred: Mus musculus, Similar to TAK1-binding protein 2; KIAA0733 protein, clone MGC:8010 IMAGE:3586132, mRNA, complete cds, full insert sequence. [A KLA 1.14 1.02 1.07 1.03 1.13 1.02 .96
ATP 1.00 .88 .92 .90 1.06 .96 .94
KLA/ATP 1.05 1.00 .90 .98 1.02 .97 .97
Map3k7ip
2
KLA  ATP  ATP+KLA
 NM_138667 mitogen-activated protein kinase kinase kinase 7 interacting protein 2 (Map3k7ip2), mRNA [NM_138667] KLA 3.43 3.22 3.19 2.41 2.13 1.51 1.10
ATP 1.08 1.08 .86 .81 1.30 1.32 1.02
KLA/ATP 3.34 3.66 3.00 2.58 1.80 1.52 1.61
Mm.14301
KLA  ATP  ATP+KLA
 21630282 Unknown KLA 3.97 3.92 3.89 4.78 4.16 4.22 3.83
ATP .97 .93 1.27 1.16 1.01 2.62 4.12
KLA/ATP 3.93 4.01 4.75 4.44 4.41 3.51 5.56
Mm.17516
3
KLA  ATP  ATP+KLA
 83699405 Unknown KLA .98 .99 1.01 .95 .99 1.06 .96
ATP 1.03 1.00 1.07 1.02 1.02 .98 .97
KLA/ATP 1.01 1.08 1.03 1.00 1.03 .93 .97
Mm.21036
1
KLA  ATP  ATP+KLA
 158508719 Unknown KLA 1.12 1.15 1.09 1.20 1.18 1.33 1.23
ATP 1.05 1.18 1.10 1.41 1.26 1.25 1.23
KLA/ATP 1.22 1.40 1.22 1.54 1.24 1.28 1.49
Mm.21312
8
KLA  ATP  ATP+KLA
 141801344 Unknown KLA .96 .95 .83 .77 .52 .99 1.32
ATP .80 .82 1.09 .80 .83 1.19 1.46
KLA/ATP .78 .92 .98 .62 .71 .94 1.41
Mm.23692
KLA  ATP  ATP+KLA
 164565453 Unknown KLA .83 .77 .72 .65 .61 .75 .80
ATP .77 .94 1.03 .63 .61 .74 .59
KLA/ATP .58 .78 .77 .52 .51 .56 .30
Mm.24936
4
KLA  ATP  ATP+KLA
 133892283 Unknown KLA 1.42 1.41 1.61 2.14 2.88 2.49 2.03
ATP .98 .98 .76 .77 1.09 1.23 1.28
KLA/ATP 1.32 1.32 1.07 1.12 1.38 1.85 1.95
Mm.25381
9
KLA  ATP  ATP+KLA
 118130676 Unknown KLA 1.81 1.88 1.96 1.62 1.89 2.44 1.56
ATP .92 .91 1.24 1.01 1.16 2.06 1.95
KLA/ATP 1.62 1.86 1.86 1.41 1.89 2.37 1.97
Mm.25500
3
KLA  ATP  ATP+KLA
 161484596 Unknown KLA .35 .34 .35 .34 .22 .19 .10
ATP 1.09 1.27 1.13 1.29 2.25 1.66 2.22
KLA/ATP .38 .36 .39 .40 .49 .42 .32
Mm.27304
9
KLA  ATP  ATP+KLA
 119672895 Unknown KLA .23 .22 .22 .22 .30 .51 .16
ATP 1.08 1.05 .88 .78 .47 .09 .20
KLA/ATP .28 .22 .21 .24 .26 .22 .12
Mm.37708
7
KLA  ATP  ATP+KLA
 158631169 Unknown KLA .98 .98 1.06 1.06 .91 .97 1.04
ATP 1.00 1.07 1.01 1.06 1.09 .99 1.02
KLA/ATP 1.08 1.06 1.16 1.11 1.16 1.12 1.04
Mm.37899
0
KLA  ATP  ATP+KLA
 144227203 Unknown KLA 5.51 4.67 4.55 6.22 4.34 4.26 2.87
ATP 1.00 .76 .68 .41 .53 3.65 1.93
KLA/ATP 4.53 4.63 5.45 2.73 3.51 4.58 3.75
Mm.38049
KLA  ATP  ATP+KLA
 118130391 Unknown KLA .67 .65 .73 .92 .63 .81 .76
ATP .93 .92 1.08 .54 .45 1.48 1.56
KLA/ATP .57 .65 .98 .67 .44 .78 1.16
Mm.41274
5
KLA  ATP  ATP+KLA
 110681696 Unknown KLA .97 1.07 1.11 1.07 1.38 1.63 1.35
ATP 1.06 1.09 1.05 1.29 1.04 .50 .56
KLA/ATP 1.11 1.12 1.04 1.11 .92 .83 .74
Mm.44889
KLA  ATP  ATP+KLA
 157057165 Unknown KLA 1.20 1.25 1.45 1.49 1.63 1.70 1.66
ATP 1.00 1.03 1.03 1.00 1.12 1.06 1.23
KLA/ATP 1.25 1.15 1.16 1.16 1.15 1.41 1.71
Mm.46002
4
KLA  ATP  ATP+KLA
 38348245 Unknown KLA 1.22 1.25 1.25 1.19 1.22 1.47 1.14
ATP 1.03 .94 1.01 1.01 2.67 2.31 1.37
KLA/ATP 1.35 1.19 1.27 1.22 1.99 1.83 1.45
Mm.57127
KLA  ATP  ATP+KLA
 117168292 Unknown KLA 1.20 1.25 1.28 1.18 1.14 1.13 1.12
ATP .98 .95 1.11 1.06 1.05 1.05 1.09
KLA/ATP 1.22 1.24 1.48 1.55 1.40 1.21 1.07
Msn
KLA  ATP  ATP+KLA
 NM_010833 moesin (Msn), mRNA [NM_010833] KLA 1.50 1.65 1.89 1.55 1.91 1.89 1.87
ATP 1.12 1.47 .86 1.52 1.07 1.00 1.33
KLA/ATP 1.76 2.01 1.10 2.07 .92 1.16 1.66
Mx2
KLA  ATP  ATP+KLA
 NM_013606 myxovirus (influenza virus) resistance 2 (Mx2), mRNA [NM_013606] KLA 80.14 64.79 53.92 46.34 41.28 43.08 14.59
ATP 1.31 1.14 1.23 1.56 2.44 18.08 7.52
KLA/ATP 80.41 69.29 77.21 58.46 40.11 46.89 57.79
Myd88
KLA  ATP  ATP+KLA
 NM_010851 myeloid differentiation primary response gene 88 (Myd88), mRNA [NM_010851] KLA 3.35 3.51 3.91 4.13 4.13 3.62 2.53
ATP .99 .96 .79 .75 .93 2.15 1.60
KLA/ATP 3.37 3.52 3.52 3.48 2.81 3.03 3.33
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nfkbia
KLA  ATP  ATP+KLA
 NM_010907 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia), mRNA [NM_010907] KLA 18.65 18.46 13.63 17.88 14.25 9.17 7.92
ATP .91 1.09 7.11 32.39 17.44 10.49 1.72
KLA/ATP 15.57 17.66 15.73 23.91 13.83 10.73 9.48
Nfkbib
KLA  ATP  ATP+KLA
 NM_010908 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (Nfkbib), mRNA [NM_010908] KLA 4.63 4.69 4.36 4.27 4.23 2.52 2.17
ATP 1.11 1.22 1.55 4.23 4.93 3.66 1.76
KLA/ATP 4.71 5.41 4.58 7.08 6.20 4.73 4.11
Oas1a
KLA  ATP  ATP+KLA
 NM_145211 2-5 oligoadenylate synthetase 1A (Oas1a), mRNA [NM_145211] KLA 2.26 2.33 2.50 2.33 3.11 3.74 3.99
ATP .99 1.04 .93 1.03 .91 1.63 3.44
KLA/ATP 2.49 2.39 1.91 2.51 2.28 3.09 6.06
Oas1b
KLA  ATP  ATP+KLA
 NM_001083925 2-5 oligoadenylate synthetase 1B (Oas1b), mRNA [NM_001083925] KLA 3.54 3.55 4.22 4.22 4.93 5.27 4.14
ATP 1.13 1.08 1.05 1.19 1.06 2.13 2.67
KLA/ATP 3.53 3.76 3.24 5.16 4.36 4.05 7.31
Oas1g
KLA  ATP  ATP+KLA
 NM_011852 2-5 oligoadenylate synthetase 1G (Oas1g), mRNA [NM_011852] KLA 2.58 2.75 2.53 2.84 2.60 2.74 2.56
ATP .97 1.03 1.20 1.17 1.07 1.82 2.47
KLA/ATP 2.58 2.80 2.68 2.60 2.21 2.27 3.01
Oas2
KLA  ATP  ATP+KLA
 NM_145227 2-5 oligoadenylate synthetase 2 (Oas2), mRNA [NM_145227] KLA 3.37 3.26 3.43 2.80 3.59 3.57 2.15
ATP 1.10 1.20 1.04 .86 .94 3.23 3.09
KLA/ATP 3.85 3.75 3.15 3.70 4.00 5.52 7.31
Oas3
KLA  ATP  ATP+KLA
 NM_145226 2-5 oligoadenylate synthetase 3 (Oas3), mRNA [NM_145226] KLA 2.32 2.35 2.67 2.63 3.37 3.80 4.07
ATP 1.06 1.10 1.02 1.26 1.02 1.47 3.58
KLA/ATP 2.62 2.57 2.39 3.18 2.67 3.05 6.15
Pik3ca
KLA  ATP  ATP+KLA
 ENSMUST00000108243 ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] KLA 1.07 1.01 .91 .90 .98 .96 .86
ATP 1.03 .87 1.12 .63 1.22 1.86 .60
KLA/ATP 1.05 .82 .91 .61 1.17 1.26 .63
Pik3ca
KLA  ATP  ATP+KLA
 NM_008839 phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] KLA 1.15 1.11 1.05 .82 .99 1.03 1.27
ATP .98 1.00 .79 .75 .96 1.32 1.10
KLA/ATP 1.10 .98 .64 .72 .80 1.20 1.41
Pik3cb
KLA  ATP  ATP+KLA
 NM_029094 phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] KLA 1.06 1.06 1.03 .73 .68 .98 1.69
ATP 1.04 1.21 .95 1.02 .85 .93 1.73
KLA/ATP 1.15 1.27 .73 .83 .58 .81 1.81
Pik3cd
KLA  ATP  ATP+KLA
 NM_008840 phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] KLA 2.28 2.42 3.10 4.17 3.35 2.31 1.34
ATP 1.02 .91 .99 .63 .30 .67 .80
KLA/ATP 2.14 2.23 2.70 1.51 1.17 .85 .72
Pik3cd
KLA  ATP  ATP+KLA
 U86587 phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] KLA 2.21 2.24 3.71 3.17 3.67 2.66 1.48
ATP 1.00 1.03 .93 .96 .46 .75 .97
KLA/ATP 2.27 2.32 1.97 2.02 1.01 .99 .98
Pik3cg
KLA  ATP  ATP+KLA
 NM_020272 phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] KLA .53 .53 .61 .64 .97 .86 .79
ATP 1.01 1.13 .88 .89 .52 .53 .53
KLA/ATP .58 .53 .43 .60 .40 .43 .62
Pik3r1
KLA  ATP  ATP+KLA
 NM_001077495 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] KLA 1.05 1.07 1.03 1.00 1.01 1.20 .85
ATP .97 1.02 1.48 1.42 1.76 1.33 1.23
KLA/ATP 1.11 1.12 1.06 1.17 1.24 .99 1.12
Pik3r2
KLA  ATP  ATP+KLA
 NM_008841 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] KLA .50 .50 .48 .43 .46 .66 .75
ATP .78 .68 .45 .43 .28 .57 1.37
KLA/ATP .49 .38 .32 .33 .38 .67 1.10
Pik3r3
KLA  ATP  ATP+KLA
 NM_181585 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] KLA 1.59 1.49 1.37 1.17 1.05 1.55 1.41
ATP 1.12 1.00 1.33 1.70 2.01 2.37 2.02
KLA/ATP 1.63 1.54 1.58 1.70 2.43 2.68 1.92
Pik3r5
KLA  ATP  ATP+KLA
 NM_177320 phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] KLA 3.57 3.58 4.16 3.54 4.11 2.59 2.39
ATP 1.08 1.08 .93 1.67 3.11 1.88 1.34
KLA/ATP 3.91 3.70 3.30 3.80 2.70 2.04 3.00
Prkcq
KLA  ATP  ATP+KLA
 AK085546 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630039J01 product:protein kinase C, theta, full insert sequence [AK085546] KLA .98 .99 1.01 1.00 .95 .98 .97
ATP 1.06 .98 1.02 1.00 .99 .99 1.04
KLA/ATP .91 1.01 .84 1.02 1.03 1.00 1.03
Prkcq
KLA  ATP  ATP+KLA
 NM_008859 protein kinase C, theta (Prkcq), mRNA [NM_008859] KLA 1.04 1.07 1.00 1.06 1.02 .91 .87
ATP 1.06 .97 .97 .99 .94 1.00 .89
KLA/ATP 1.09 1.00 1.15 1.14 .98 1.07 .96
Rab9
KLA  ATP  ATP+KLA
 NM_019773 RAB9, member RAS oncogene family (Rab9), mRNA [NM_019773] KLA 3.82 4.03 3.96 3.23 1.88 1.37 1.13
ATP .99 .99 1.32 1.64 2.75 2.45 1.67
KLA/ATP 3.86 3.98 5.25 5.27 6.26 3.99 2.06
Rab9b
KLA  ATP  ATP+KLA
 NM_176971 RAB9B, member RAS oncogene family (Rab9b), mRNA [NM_176971] KLA .94 .96 .95 .99 .96 .97 1.00
ATP 1.03 .97 1.00 1.03 .97 .97 .96
KLA/ATP .98 1.00 .99 .94 .92 .96 .94
Rchy1
KLA  ATP  ATP+KLA
 NM_026557 ring finger and CHY zinc finger domain containing 1 (Rchy1), mRNA [NM_026557] KLA .51 .57 .70 1.01 1.04 .77 .66
ATP .97 .91 .91 .94 .99 .76 1.05
KLA/ATP .48 .50 .61 .62 .85 .97 .97
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Sh2d1a
KLA  ATP  ATP+KLA
 AK042476 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630095D20 product:SH2 domain protein 1A, full insert sequence. [AK042476] KLA .93 .99 1.01 .99 .98 1.02 1.02
ATP .99 .96 .96 .99 1.08 1.01 .98
KLA/ATP .97 1.07 1.03 1.05 .94 .94 .95
Sh2d1a
KLA  ATP  ATP+KLA
 NM_011364 SH2 domain protein 1A (Sh2d1a), mRNA [NM_011364] KLA 1.04 .97 1.00 1.02 .98 .99 1.00
ATP .95 .98 .97 1.01 .99 1.05 1.03
KLA/ATP .99 1.04 1.01 .97 1.05 .99 1.02
Slamf1
KLA  ATP  ATP+KLA
 NM_013730 signaling lymphocytic activation molecule family member 1 (Slamf1), mRNA [NM_013730] KLA 2.22 2.46 3.25 3.19 5.11 3.88 1.69
ATP 1.01 1.03 1.10 1.17 1.30 2.60 1.35
KLA/ATP 2.30 2.56 2.36 3.77 4.27 9.40 17.34
Stat1
KLA  ATP  ATP+KLA
 NM_009283 signal transducer and activator of transcription 1 (Stat1), mRNA [NM_009283] KLA 2.90 2.72 3.00 3.64 4.58 6.51 5.58
ATP 1.01 .92 .89 .72 .51 2.22 3.07
KLA/ATP 2.73 2.65 2.34 1.95 1.99 4.70 8.66
Stat2
KLA  ATP  ATP+KLA
 NM_019963 signal transducer and activator of transcription 2 (Stat2), mRNA [NM_019963] KLA 5.64 4.80 4.99 6.48 6.28 9.50 5.36
ATP .90 .80 1.03 .66 .97 4.90 4.07
KLA/ATP 4.47 4.88 6.34 4.27 6.76 9.49 11.43
Stat3
KLA  ATP  ATP+KLA
 NM_213659 signal transducer and activator of transcription 3 (Stat3), transcript variant 1, mRNA [NM_213659] KLA 4.36 4.42 4.67 6.02 4.95 3.45 1.46
ATP 1.01 .97 1.07 1.17 2.47 4.04 1.47
KLA/ATP 4.02 4.57 6.65 6.51 7.06 7.39 3.61
Stat5a
KLA  ATP  ATP+KLA
 NM_011488 signal transducer and activator of transcription 5A (Stat5a), mRNA [NM_011488] KLA 8.23 8.24 6.89 4.88 4.35 1.98 1.01
ATP 1.07 1.14 1.07 1.26 3.23 3.14 1.52
KLA/ATP 8.70 9.53 7.33 6.68 4.32 2.73 1.72
Stat5b
KLA  ATP  ATP+KLA
 AK137889 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130035C01 product:unclassifiable, full insert sequence. [AK137889] KLA 1.10 1.01 .98 .90 1.03 .93 .88
ATP .90 .87 .61 .69 1.01 .97 .89
KLA/ATP 1.12 1.00 .87 .85 .95 1.07 .83
Stat5b
KLA  ATP  ATP+KLA
 NM_011489 signal transducer and activator of transcription 5B (Stat5b), transcript variant 1, mRNA [NM_011489] KLA 2.91 2.81 3.42 2.69 2.23 1.95 1.32
ATP .99 1.04 1.16 .97 1.00 1.84 2.09
KLA/ATP 2.96 3.05 3.17 2.99 1.86 1.87 3.40
Tacr1
KLA  ATP  ATP+KLA
 NM_009313 tachykinin receptor 1 (Tacr1), mRNA [NM_009313] KLA 1.21 1.16 1.23 1.08 1.14 1.12 1.06
ATP 1.05 1.03 1.06 1.01 1.00 1.02 1.09
KLA/ATP 1.16 1.23 1.06 1.22 1.10 1.07 1.08
Tbk1
KLA  ATP  ATP+KLA
 NM_019786 TANK-binding kinase 1 (Tbk1), mRNA [NM_019786] KLA 2.55 2.76 3.22 2.67 2.56 2.29 1.96
ATP 1.13 1.30 1.12 1.07 1.29 1.41 1.40
KLA/ATP 2.84 3.17 2.58 2.43 1.70 2.15 2.37
Tlr2
KLA  ATP  ATP+KLA
 NM_011905 toll-like receptor 2 (Tlr2), mRNA [NM_011905] KLA 13.65 11.82 8.87 7.95 4.67 2.78 2.33
ATP 1.06 1.24 2.76 6.28 11.55 13.82 .67
KLA/ATP 13.11 12.91 14.48 13.84 14.18 11.14 2.78
Tlr4
KLA  ATP  ATP+KLA
 NM_021297 toll-like receptor 4 (Tlr4), mRNA [NM_021297] KLA .69 .61 .75 .94 .64 .81 .73
ATP .95 .90 1.12 .56 .47 1.51 1.53
KLA/ATP .57 .62 1.01 .64 .39 .73 1.13
Tlr7
KLA  ATP  ATP+KLA
 NM_133211 toll-like receptor 7 (Tlr7), mRNA [NM_133211] KLA 2.03 2.09 2.28 2.43 2.56 2.48 1.32
ATP 1.01 1.06 1.05 .80 .80 .89 1.37
KLA/ATP 2.04 2.28 2.28 2.40 2.28 1.77 1.06
Tlr9
KLA  ATP  ATP+KLA
 NM_031178 toll-like receptor 9 (Tlr9), mRNA [NM_031178] KLA 1.08 1.09 1.18 1.15 1.34 1.25 1.16
ATP 1.04 1.05 1.23 1.85 1.41 1.06 1.21
KLA/ATP 1.16 1.17 1.45 1.88 1.67 1.32 1.46
Tnfaip3
KLA  ATP  ATP+KLA
 NM_009397 tumor necrosis factor, alpha-induced protein 3 (Tnfaip3), mRNA [NM_009397] KLA 29.69 27.73 21.42 18.86 14.42 8.13 7.48
ATP 1.73 4.86 21.57 43.06 30.03 18.86 8.31
KLA/ATP 29.39 35.88 40.64 52.71 33.19 25.38 17.75
Tnfrsf10
b
KLA  ATP  ATP+KLA
 NM_020275 tumor necrosis factor receptor superfamily, member 10b (Tnfrsf10b), mRNA [NM_020275] KLA 1.29 1.24 1.23 1.14 .96 .88 .87
ATP .99 1.04 1.06 1.14 .95 1.10 1.15
KLA/ATP 1.26 1.26 1.21 1.23 1.03 .93 .93
Tnfsf10
KLA  ATP  ATP+KLA
 NM_009425 tumor necrosis factor (ligand) superfamily, member 10 (Tnfsf10), mRNA [NM_009425] KLA 31.48 31.73 32.62 36.94 28.34 23.40 4.96
ATP 1.06 .93 1.28 1.24 1.07 2.74 3.33
KLA/ATP 28.07 30.23 43.53 33.98 27.97 18.71 17.43
Traf6
KLA  ATP  ATP+KLA
 NM_009424 Tnf receptor-associated factor 6 (Traf6), mRNA [NM_009424] KLA 1.19 1.28 1.34 1.20 1.23 1.23 1.28
ATP 1.06 1.12 .92 1.15 2.46 1.84 1.40
KLA/ATP 1.32 1.37 .89 1.16 1.45 1.49 1.46
Trp53
KLA  ATP  ATP+KLA
 NM_011640 transformation related protein 53 (Trp53), mRNA [NM_011640] KLA 1.25 1.37 1.11 .86 .72 .71 .95
ATP 1.15 1.32 .90 1.85 1.26 .68 .70
KLA/ATP 1.66 1.49 .80 1.76 .81 .65 .74
Trp73
KLA  ATP  ATP+KLA
 BC069182 transformation related protein 73, mRNA (cDNA clone IMAGE:6826464) [BC069182] KLA .98 1.00 .95 .99 1.04 1.03 1.00
ATP 1.01 .97 1.01 1.06 1.04 1.01 1.08
KLA/ATP 1.02 .96 1.00 1.07 1.06 1.07 1.00
Trp73
KLA  ATP  ATP+KLA
 NM_011642 transformation related protein 73 (Trp73), mRNA [NM_011642] KLA 1.66 1.63 1.93 1.60 2.12 1.64 1.57
ATP 1.05 1.07 1.14 1.28 1.19 1.07 1.24
KLA/ATP 1.73 1.86 1.60 1.94 1.48 1.23 1.52
Tyk2
KLA  ATP  ATP+KLA
 NM_018793 tyrosine kinase 2 (Tyk2), mRNA [NM_018793] KLA 2.91 2.95 3.42 3.26 3.85 2.35 1.42
ATP 1.09 1.01 .68 .64 .59 .86 1.10
KLA/ATP 2.95 3.04 2.23 1.82 1.24 1.27 2.09